Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q4 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
N/A
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 605 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$48.05M
Operating Margin
-230.92%
TTM Avg
-150.83%
3Y Avg
-322.13%
5Y Avg
-477.29%
Market Cap
$45.37M
Operating Margin
-163.94%
TTM Avg
-188.75%
3Y Avg
-214.75%
5Y Avg
-271.10%
Market Cap
$49.20M
Operating Margin
-11541.50%
TTM Avg
-10608.91%
3Y Avg
-9412.76%
5Y Avg
-9062.71%
Market Cap
$49.47M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$44.81M
Operating Margin
0.00%
TTM Avg
-1952.10%
3Y Avg
-1112.27%
5Y Avg
-741.51%
Market Cap
$44.16M
Operating Margin
-1.45%
TTM Avg
4.45%
3Y Avg
-26.46%
5Y Avg
-35.98%
Market Cap
$44.20M
Operating Margin
-466.16%
TTM Avg
-484.55%
3Y Avg
-719.99%
5Y Avg
-1266.78%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lite Strategy, Inc. (LITS) | $47.64M | 0.00% | 0.00% | N/A | N/A |
| Celularity Inc. (CELU)vs › | $48.05M | -230.92% | -150.83% | -322.13% | -477.29% |
| DarioHealth Corp. (DRIO)vs › | $45.37M | -163.94% | -188.75% | -214.75% | -271.10% |
| Clene Inc. (CLNN)vs › | $49.20M | -11541.50% | -10608.91% | -9412.76% | -9062.71% |
| Microbot Medical Inc. (MBOT)vs › | $49.47M | 0.00% | 0.00% | 0.00% | 0.00% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.81M | 0.00% | -1952.10% | -1112.27% | -741.51% |
| BioStem Technologies, Inc. (BSEM)vs › | $44.16M | -1.45% | 4.45% | -26.46% | -35.98% |
| Nano-X Imaging Ltd. (NNOX)vs › | $44.20M | -466.16% | -484.55% | -719.99% | -1266.78% |
| biote Corp. (BTMD)vs › | $50.28M | 18.50% | 17.27% | 3.29% | 10.87% |
| INmune Bio, Inc. (INMB)vs › | $50.64M | -61738.00% | -183136.86% | -98100.06% | -86611.75% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
